Phase I / II clinical trial, randomized, exploratory and prospective toevaluate the safety and efficacy of the transfusion of autologous TREG cellsobtained from thymic tissue in the prevention of rejection in hearttransplanted children

Category Primary study
Registry of TrialsClinical Trials Information System
Year 2025
This article has no abstract
Epistemonikos ID: 9f17887046fe28758ea44e8020aaf7953b6c3150
First added on: Mar 21, 2025